Immunoblotting was performed to quantify CAMKK2 protein levels in the temporal cortex tissues derived from AD patients and CN individuals, postmortem (Figures 4A, D, and Supplementary Figures S1A, D). The gene discussed is CAMKK2; the disease is Alzheimer disease.